Pew: OTC Monograph Bill Needed In Light Of Stagnant Funding Levels

Recently unveiled over-the-counter (OTC) monograph legislation is all the more important to reducing the monograph backlog given that FDA's fiscal 2018 budget justification maintains fiscal 2017 funding levels for the agency's OTC review processes, the Pew Charitable Trusts recently recently told Inside Health Policy . Despite stagnant funding levels, the group was encouraged by a recent request from appropriators for a status report on OTC's monograph reviews. FDA's fiscal 2018 budget justification maintains the same funding levels for OTC product...